The role of transbronchial biopsies in the management of lung transplant recipients

R. K. Sibley, G. J. Berry, H. D. Tazelaar, M. R. Kraemer, J. Theodore, S. E. Marshall, M. E. Billingham, V. A. Starnes

Research output: Contribution to journalArticle

104 Citations (Scopus)

Abstract

We examined the utility of the transbronchial biopsy in the management of 53 lung transplant patients. One hundred thirty-three protocol biopsies were performed to ascertain the frequency and nature of abnormalities in clinically stable or asymptomatic patients; 128 diagnostic biopsies were performed in clinically ill patients to assess the morphologic abnormalities before the institution of therapy, and 105 biopsies were performed to assess the response to therapy. Histologic evidence of acute rejection was found in 24% of the protocol biopsies, and infection was found in 17%. Twenty-five patients with grade 1 or grade 2 perivascular infiltrates in protocol biopsies did not receive antirejection therapy. Follow-up biopsy in these patients showed spontaneous resolution of the infiltrates in 19% and increased infiltrates in 6. Only two of these patients became clinically ill, representing 'progression' to clinical rejection in only 8% of the nontreated patients. Forty percent of the biopsies performed to rule out acute rejection or infection had histologic features of acute rejection, and another 23% had features of infection. Treatment of patients with clinical and histologic evidence of rejection was associated with rapid resolution of clinical symptoms in nearly 90% of the patients, but follow-up biopsies showed residual infiltrates compatible with ongoing or resolving rejection in 52%. Despite repeat antirejection therapy in some patients, these infiltrates persisted for an average of 30 days after the diagnostic biopsy. Follow-up biopsies also showed asymptomatic infection, usually cytomegalovirus pneumonitis, which often persisted for weeks despite the lack of symptoms. Perivascular infiltrates compatible with acute rejection were also found in 38% of biopsy specimens with evidence of infection. These perivascular infiltrates resolved with antibiotic treatment alone in nearly 50% of the patients with these features. Although perivascular mononuclear cell infiltrates are the cardinal histologic feature of acute rejection, similar infiltrates occur in patients who apparently have infection alone and other patients who have both infection and rejection; infiltrates compatible with minimal, mild, and moderate acute rejection also occur in clinically asymptomatic patients. These histologic findings are a challenge to both the pathologists' and the clinicians' skills in the management of the lung transplant patient.

Original languageEnglish (US)
Pages (from-to)308-324
Number of pages17
JournalJournal of Heart and Lung Transplantation
Volume12
Issue number2
StatePublished - 1993
Externally publishedYes

Fingerprint

Biopsy
Lung
Infection
Transplant Recipients
Immunosuppression
Transplants
Asymptomatic Infections
Therapeutics
Cytomegalovirus
Pneumonia
Anti-Bacterial Agents

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery
  • Transplantation

Cite this

Sibley, R. K., Berry, G. J., Tazelaar, H. D., Kraemer, M. R., Theodore, J., Marshall, S. E., ... Starnes, V. A. (1993). The role of transbronchial biopsies in the management of lung transplant recipients. Journal of Heart and Lung Transplantation, 12(2), 308-324.

The role of transbronchial biopsies in the management of lung transplant recipients. / Sibley, R. K.; Berry, G. J.; Tazelaar, H. D.; Kraemer, M. R.; Theodore, J.; Marshall, S. E.; Billingham, M. E.; Starnes, V. A.

In: Journal of Heart and Lung Transplantation, Vol. 12, No. 2, 1993, p. 308-324.

Research output: Contribution to journalArticle

Sibley, RK, Berry, GJ, Tazelaar, HD, Kraemer, MR, Theodore, J, Marshall, SE, Billingham, ME & Starnes, VA 1993, 'The role of transbronchial biopsies in the management of lung transplant recipients', Journal of Heart and Lung Transplantation, vol. 12, no. 2, pp. 308-324.
Sibley RK, Berry GJ, Tazelaar HD, Kraemer MR, Theodore J, Marshall SE et al. The role of transbronchial biopsies in the management of lung transplant recipients. Journal of Heart and Lung Transplantation. 1993;12(2):308-324.
Sibley, R. K. ; Berry, G. J. ; Tazelaar, H. D. ; Kraemer, M. R. ; Theodore, J. ; Marshall, S. E. ; Billingham, M. E. ; Starnes, V. A. / The role of transbronchial biopsies in the management of lung transplant recipients. In: Journal of Heart and Lung Transplantation. 1993 ; Vol. 12, No. 2. pp. 308-324.
@article{fb02690edc4040758bf8660365f102c1,
title = "The role of transbronchial biopsies in the management of lung transplant recipients",
abstract = "We examined the utility of the transbronchial biopsy in the management of 53 lung transplant patients. One hundred thirty-three protocol biopsies were performed to ascertain the frequency and nature of abnormalities in clinically stable or asymptomatic patients; 128 diagnostic biopsies were performed in clinically ill patients to assess the morphologic abnormalities before the institution of therapy, and 105 biopsies were performed to assess the response to therapy. Histologic evidence of acute rejection was found in 24{\%} of the protocol biopsies, and infection was found in 17{\%}. Twenty-five patients with grade 1 or grade 2 perivascular infiltrates in protocol biopsies did not receive antirejection therapy. Follow-up biopsy in these patients showed spontaneous resolution of the infiltrates in 19{\%} and increased infiltrates in 6. Only two of these patients became clinically ill, representing 'progression' to clinical rejection in only 8{\%} of the nontreated patients. Forty percent of the biopsies performed to rule out acute rejection or infection had histologic features of acute rejection, and another 23{\%} had features of infection. Treatment of patients with clinical and histologic evidence of rejection was associated with rapid resolution of clinical symptoms in nearly 90{\%} of the patients, but follow-up biopsies showed residual infiltrates compatible with ongoing or resolving rejection in 52{\%}. Despite repeat antirejection therapy in some patients, these infiltrates persisted for an average of 30 days after the diagnostic biopsy. Follow-up biopsies also showed asymptomatic infection, usually cytomegalovirus pneumonitis, which often persisted for weeks despite the lack of symptoms. Perivascular infiltrates compatible with acute rejection were also found in 38{\%} of biopsy specimens with evidence of infection. These perivascular infiltrates resolved with antibiotic treatment alone in nearly 50{\%} of the patients with these features. Although perivascular mononuclear cell infiltrates are the cardinal histologic feature of acute rejection, similar infiltrates occur in patients who apparently have infection alone and other patients who have both infection and rejection; infiltrates compatible with minimal, mild, and moderate acute rejection also occur in clinically asymptomatic patients. These histologic findings are a challenge to both the pathologists' and the clinicians' skills in the management of the lung transplant patient.",
author = "Sibley, {R. K.} and Berry, {G. J.} and Tazelaar, {H. D.} and Kraemer, {M. R.} and J. Theodore and Marshall, {S. E.} and Billingham, {M. E.} and Starnes, {V. A.}",
year = "1993",
language = "English (US)",
volume = "12",
pages = "308--324",
journal = "Journal of Heart and Lung Transplantation",
issn = "1053-2498",
publisher = "Elsevier USA",
number = "2",

}

TY - JOUR

T1 - The role of transbronchial biopsies in the management of lung transplant recipients

AU - Sibley, R. K.

AU - Berry, G. J.

AU - Tazelaar, H. D.

AU - Kraemer, M. R.

AU - Theodore, J.

AU - Marshall, S. E.

AU - Billingham, M. E.

AU - Starnes, V. A.

PY - 1993

Y1 - 1993

N2 - We examined the utility of the transbronchial biopsy in the management of 53 lung transplant patients. One hundred thirty-three protocol biopsies were performed to ascertain the frequency and nature of abnormalities in clinically stable or asymptomatic patients; 128 diagnostic biopsies were performed in clinically ill patients to assess the morphologic abnormalities before the institution of therapy, and 105 biopsies were performed to assess the response to therapy. Histologic evidence of acute rejection was found in 24% of the protocol biopsies, and infection was found in 17%. Twenty-five patients with grade 1 or grade 2 perivascular infiltrates in protocol biopsies did not receive antirejection therapy. Follow-up biopsy in these patients showed spontaneous resolution of the infiltrates in 19% and increased infiltrates in 6. Only two of these patients became clinically ill, representing 'progression' to clinical rejection in only 8% of the nontreated patients. Forty percent of the biopsies performed to rule out acute rejection or infection had histologic features of acute rejection, and another 23% had features of infection. Treatment of patients with clinical and histologic evidence of rejection was associated with rapid resolution of clinical symptoms in nearly 90% of the patients, but follow-up biopsies showed residual infiltrates compatible with ongoing or resolving rejection in 52%. Despite repeat antirejection therapy in some patients, these infiltrates persisted for an average of 30 days after the diagnostic biopsy. Follow-up biopsies also showed asymptomatic infection, usually cytomegalovirus pneumonitis, which often persisted for weeks despite the lack of symptoms. Perivascular infiltrates compatible with acute rejection were also found in 38% of biopsy specimens with evidence of infection. These perivascular infiltrates resolved with antibiotic treatment alone in nearly 50% of the patients with these features. Although perivascular mononuclear cell infiltrates are the cardinal histologic feature of acute rejection, similar infiltrates occur in patients who apparently have infection alone and other patients who have both infection and rejection; infiltrates compatible with minimal, mild, and moderate acute rejection also occur in clinically asymptomatic patients. These histologic findings are a challenge to both the pathologists' and the clinicians' skills in the management of the lung transplant patient.

AB - We examined the utility of the transbronchial biopsy in the management of 53 lung transplant patients. One hundred thirty-three protocol biopsies were performed to ascertain the frequency and nature of abnormalities in clinically stable or asymptomatic patients; 128 diagnostic biopsies were performed in clinically ill patients to assess the morphologic abnormalities before the institution of therapy, and 105 biopsies were performed to assess the response to therapy. Histologic evidence of acute rejection was found in 24% of the protocol biopsies, and infection was found in 17%. Twenty-five patients with grade 1 or grade 2 perivascular infiltrates in protocol biopsies did not receive antirejection therapy. Follow-up biopsy in these patients showed spontaneous resolution of the infiltrates in 19% and increased infiltrates in 6. Only two of these patients became clinically ill, representing 'progression' to clinical rejection in only 8% of the nontreated patients. Forty percent of the biopsies performed to rule out acute rejection or infection had histologic features of acute rejection, and another 23% had features of infection. Treatment of patients with clinical and histologic evidence of rejection was associated with rapid resolution of clinical symptoms in nearly 90% of the patients, but follow-up biopsies showed residual infiltrates compatible with ongoing or resolving rejection in 52%. Despite repeat antirejection therapy in some patients, these infiltrates persisted for an average of 30 days after the diagnostic biopsy. Follow-up biopsies also showed asymptomatic infection, usually cytomegalovirus pneumonitis, which often persisted for weeks despite the lack of symptoms. Perivascular infiltrates compatible with acute rejection were also found in 38% of biopsy specimens with evidence of infection. These perivascular infiltrates resolved with antibiotic treatment alone in nearly 50% of the patients with these features. Although perivascular mononuclear cell infiltrates are the cardinal histologic feature of acute rejection, similar infiltrates occur in patients who apparently have infection alone and other patients who have both infection and rejection; infiltrates compatible with minimal, mild, and moderate acute rejection also occur in clinically asymptomatic patients. These histologic findings are a challenge to both the pathologists' and the clinicians' skills in the management of the lung transplant patient.

UR - http://www.scopus.com/inward/record.url?scp=0027262264&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027262264&partnerID=8YFLogxK

M3 - Article

VL - 12

SP - 308

EP - 324

JO - Journal of Heart and Lung Transplantation

JF - Journal of Heart and Lung Transplantation

SN - 1053-2498

IS - 2

ER -